QNCX vs WRB · $79.3M cap vs P/E 17, rev $3.72B
Quince Therapeutics, Inc. (QNCX) versus W. R. Berkley Corp (WRB) — a side-by-side from cached financials, not a winner call.
Quince Therapeutics, Inc. (QNCX) is a biotechnology company listed on US.
W. R. Berkley Corp (WRB) is a insurance - property & casualty company listed on US.
QNCX does not have a complete income-statement cache yet.
Latest reported WRB revenue for 2026-06-30 was $3.72B. Net income was $452.3M. Revenue was up 0.7% from 2026-03-31 to 2026-06-30. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
QNCX currently screens at market cap $79.3M. WRB currently screens at market cap $27.12B and trailing P/E 16.6.
Not investment advice. Open the QNCX and WRB stock pages for the full models.
Not investment advice.